{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T07:31:16Z","timestamp":1648711876219},"reference-count":18,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Presentation of The Case<\/jats:title>\n                  <jats:p>A 61-year-old man undergoes a sigmoid colectomy for a T3N1 (two of 18 nodes) adenocarcinoma of the sigmoid colon. He recovers well and receives 6 months of adjuvant FOLFOX (5-fluorouracil, leucovorin, and oxaliplatin) uneventfully. At his first follow-up visit, the oncologist recommended every 3 month visits for a physical, liver function tests, and carcinoembryonic antigen (CEA) measurement; every 6 month chest, abdomen, and pelvic computed tomography (CT) scans for 3 years; and aspirin, vitamin D supplementation, and exercise. Is CT scanning appropriate in the follow-up of colon cancer patients? (This case was presented at Massachusetts General Hospital Cancer Center.)<\/jats:p>\n               <\/jats:sec>","DOI":"10.1634\/theoncologist.2011-0014","type":"journal-article","created":{"date-parts":[[2011,2,24]],"date-time":"2011-02-24T23:00:46Z","timestamp":1298588446000},"page":"254-256","source":"Crossref","is-referenced-by-count":0,"title":["Scan? Cure? Sure!"],"prefix":"10.1093","volume":"16","author":[{"given":"Richard M.","family":"Goldberg","sequence":"first","affiliation":[{"name":"University of North Carolina at Chapel Hill"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David P.","family":"Ryan","sequence":"additional","affiliation":[{"name":"Massachusetts General Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2011,1,1]]},"reference":[{"key":"2021122303223848600_B1","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1200\/JCO.2004.05.041","article-title":"The value of routine serum carcino-embryonic antigen measurement and computed tomography in the surveillance of patients after adjuvant chemotherapy for colorectal cancer","volume":"22","author":"Chau","year":"2004","journal-title":"J Clin Oncol"},{"key":"2021122303223848600_B2","doi-asserted-by":"crossref","first-page":"8512","DOI":"10.1200\/JCO.2005.04.0063","article-title":"Colorectal cancer surveillance: 2005 update of an American Society of Clinical Oncology practice guideline","volume":"23","author":"Desch","year":"2005","journal-title":"J Clin Oncol"},{"key":"2021122303223848600_B3"},{"key":"2021122303223848600_B4","first-page":"CD002200","article-title":"Follow-up strategies for patients treated for non-metastatic colorectal cancer","volume":"1","author":"Jeffery","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"2021122303223848600_B5","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1093\/annonc\/mdn786","article-title":"Prognostic significance of circulating tumor cells in patients with metastatic colorectal cancer","volume":"20","author":"Cohen","year":"2009","journal-title":"Ann Oncol"},{"key":"2021122303223848600_B6","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1002\/bjs.6735","article-title":"Systematic review of tumour number and outcome after radical treatment of colorectal liver metastases","volume":"96","author":"Smith","year":"2009","journal-title":"Br J Surg"},{"key":"2021122303223848600_B7","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1471-2407-3-26","article-title":"Follow-up of patients with curatively resected colorectal cancer: A practice guideline","volume":"3","author":"Figueredo","year":"2003","journal-title":"BMC Cancer"},{"key":"2021122303223848600_B8","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1136\/bmj.324.7341.813","article-title":"Impact on survival of intensive follow up after curative resection for colorectal cancer: Systematic review and meta-analysis of randomised trials","volume":"324","author":"Renehan","year":"2002","journal-title":"BMJ"},{"key":"2021122303223848600_B9","doi-asserted-by":"crossref","first-page":"321","DOI":"10.7326\/0003-4819-122-5-199503010-00001","article-title":"Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma: A final report","volume":"122","author":"Moertel","year":"1995","journal-title":"Ann Intern Med"},{"key":"2021122303223848600_B10","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1200\/JCO.2008.20.6771","article-title":"Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial","volume":"27","author":"Andr\u00e9","year":"2009","journal-title":"J Clin Oncol"},{"key":"2021122303223848600_R1","first-page":"619","article-title":"Follow-up after curative surgery for colorectal carcinoma. Randomized comparison with no follow-up","volume":"38","author":"Ohlsson","year":"1995","journal-title":"Br J Surg"},{"key":"2021122303223848600_R2","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1001\/archsurg.1995.01430100040009","article-title":"Five-year follow-up after radical surgery for colorectal cancer. Results of a prospective randomized trial","volume":"130","author":"Makela","year":"1995","journal-title":"Arch Surg"},{"key":"2021122303223848600_R3","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0016-5085(98)70626-2","article-title":"Yearly colonoscopy, liver CT, and chest radiography do not influence 5-year survival of colorectal cancer patients","volume":"114","author":"Schoemaker","year":"1998","journal-title":"Gastreoenterology"},{"key":"2021122303223848600_R4","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1471-2407-3-26","article-title":"Follow-up of patients with curatively resected colorectal cancer: A practical guideline","volume":"3","author":"Figueredo","year":"2003","journal-title":"BMC Cancer"},{"key":"2021122303223848600_R5","first-page":"CD002200","article-title":"Follow-up strategies for patients treated for non-metastatic colorectal cancer","volume":"1","author":"Jeffery","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"2021122303223848600_R6","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1200\/JCO.2004.05.041","article-title":"The value of routine serum carcino-embryonic antigen measurement and computed tomography in the surveillance of patients after adjuvant chemotherapy for colorectal cancer","volume":"22","author":"Chau","year":"2004","journal-title":"J Clin Onc"},{"key":"2021122303223848600_R7","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1001\/jama.291.19.2376","article-title":"Prevention of radiocontrast nephropathy: Back to basics","volume":"291","author":"Chertow","year":"2004","journal-title":"JAMA"},{"key":"2021122303223848600_R8","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1148\/radiol.2511081296","article-title":"Recurrent CT, cumulative radiation exposure, and associated radiation-induced cancer risks from CT of adults","volume":"251","author":"Sodickson","year":"2009","journal-title":"Radiology"}],"container-title":["The Oncologist"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1634\/theoncologist.2011-0014","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1634\/theoncologist.2011-0014","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/16\/2\/254\/41853021\/oncolo_16_2_254.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/16\/2\/254\/41853021\/oncolo_16_2_254.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,23]],"date-time":"2021-12-23T04:59:15Z","timestamp":1640235555000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/oncolo\/article\/16\/2\/254\/6400722"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1,1]]},"references-count":18,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2011,1,1]]},"published-print":{"date-parts":[[2011,2,1]]}},"URL":"https:\/\/doi.org\/10.1634\/theoncologist.2011-0014","relation":{},"ISSN":["1083-7159","1549-490X"],"issn-type":[{"value":"1083-7159","type":"print"},{"value":"1549-490X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2011,2,1]]},"published":{"date-parts":[[2011,1,1]]}}}